Due to an error, the database used in the above study had interchanged information on sex with those of one of the participating cohorts. Consequently, some of the results in the published article were incorrect. The authors have performed new analyses and the correct data are given below:
Due to an error, the database used in the above study had interchanged information on sex with those of one of the participating cohorts. Consequently, some of the results in the published article were incorrect. The authors have performed new analyses and the correct data are given below:
In a joint study of future risks for anal and perianal skin cancers in relation to baseline human papillomavirus (HPV) seropositivity nested in Norwegian and Finnish cohorts, it turns out that the information on sex had been interchanged in one of the Norwegian cohorts.
With correct information on sex, HPV 16 seropositivity conferred an increased risk of anal/perianal cancer of 3.6 (95% CI ¼ 1.3 -10). Overall, 27% of the female and 31% of the male cases were seropositive for HPV 16. Similar figures for HPV 18 were 27% and 8%, respectively. By dichotomisation on age and lag in the Norwegian cohort, we found that HPV 16 seropositive men above 45 years of age had an increased risk (OR ¼ 16; 95% CI ¼ 2.6 -96) as did subjects with less than 10 years lag (OR ¼ 6.9; 95% CI ¼ 1.7 -27).
The corrected data are given below (Table 1) . The authors apologise for any inconvenience this may have caused. For a complete list of corrections to the text of the article, please contact tone.bjorge@oslo.online.no 
